French drug regulator failing on conflicts of interest rules
This article was originally published in Scrip
Executive Summary
The debate surrounding conflicts of interest and whether drug regulators can find truly independent advisers without links to the pharmaceutical industry has hit one of Europe's largest agencies, the French drug and medical device regulator, Afssaps.